Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cellcor is a South Korean biotechnology company specializing in the development and manufacture of high-performance chemically defined media (CDM) for cell culture. The company's products are designed to support the growth and expansion of various cell types, including mesenchymal stem cells (MSCs), T-cells, and NK-cells, without the use of animal-derived components. By providing serum-free and chemically defined solutions, Cellcor aims to enhance the safety, consistency, and scalability of cell-based therapies and exosome production. Their portfolio includes specialized media such as K-STem and K-Lympho, catering to the global regenerative medicine and biopharmaceutical industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cellcor.